Searchable abstracts of presentations at key conferences in endocrinology

ea0099p285 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

A cost-effectiveness analysis of inpatient continuous glucose monitoring vs capillary blood glucose

Verissimo David , R Pereira Beatriz , Vinhais Joana , Ivo Catarina , Claudia Martins Ana , Silva Joao , Passos Dolores , Lopes Luis , Jacome Castro J , Marcelino Mafalda

Introduction: We conducted a prospective study to compare the efficacy of continuous glucose monitoring (CGM) devices versus capillary blood glucose (CBG) in the glycemic control of inpatient type 2 diabetes on intensive insulin therapy. The use of CGM was associated with improved glycemic control, including an increased time in range (TIR) and reduced hyperglycemic events, being safe concerning hypoglycemias. The present study is the cost-effectiveness analysis associated wit...

ea0099ep426 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

SGLT-2 inhibitors-induced erythrocytosis: a case series

Verissimo David , R Pereira Beatriz , Vinhais Joana , Ivo Catarina , Claudia Martins Ana , Silva Joao , Passos Dolores , Lopes Luis , Jacome Castro J , Marcelino Mafalda

Introduction: Sodium-glucose co-transporter 2 inhibitors (SGLT2i) have emerged as a promising class of medications, demonstrating a significant reduction in the risk of cardiovascular events. An associated consequence of SGLT2i is an increase in hematocrit levels, with cardiovascular outcome trials revealing frequent hematocrit mean elevations varying from +2.3% to 3.5%. This rise in hematocrit introduces a potential dilemma when evaluating the risk-benefit profile of SGLT2i i...

ea0099ep963 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Immune checkpoint inhibitor-associated diabetes mellitus

Vinhais Joana , R. Pereira Beatriz , Verissimo David , Ivo Catarina , Claudia Martins Ana , Nunes e Silva Joao , Passos Dolores , Lopes Luis , Jacome de Castro Joao , Marcelino Mafalda

Introduction: The immune checkpoint inhibitors (ICI) are increasingly being used in the treatment of several malignancies. ICI are monoclonal antibodies that inhibit immune checkpoints, thus stimulating the action of the immune cells to attack the tumour cells. The overstimulation of the immune system can lead to several endocrinopathies, such as autoimmune diabetes, known as ICI-associated diabetes mellitus (ICIDM).Case Report: In September 2023, a 62-y...

ea0099ep191 | Endocrine-Related Cancer | ECE2024

Proteins and peptides from granin family in patients with adrenal incidentalomas and PPGLs

Szatko Alicja , Leszczynska Dorota , Sawicka-Gutaj Nadia , Bromińska Barbara , Ambroziak Urszula , Papierska Lucyna , Araujo Castro Marta , Falhammar Henrik , Zgliczyński Wojciech , Glinicki Piotr

Introduction: Adrenal incidentalomas are tumors incidentally discovered on imaging tests. Regarding functionality, although 75% of adrenal incidentalomas are non-functioning cortical adenomas (NFAA), there is a subset of adrenal incidentalomas associated with important clinical consequences: adrenocortical cancer (ACC), pheochromocytoma (PHEO, together with paraganglioma (PGL) referred as PPGL), primary aldosteronism (PA), mild-autonomous cortisol secretion (MACS) and Cushing ...

ea0081p417 | Pituitary and Neuroendocrinology | ECE2022

Terlipressin induced acute severe hyponatremia

Pla Peris Begona , Castro de la Vega Iciar , Roxana Padilla Segura Mayet , Serisuelo Meneu Esther , Abellan Galiana Pablo , Maravall Javier , Perez Naranjo Susana , Gonzalez Boillos Margarita , Angel Merchante Alfaro Agustin

Introduction: Terlipressin is a non-selective vasopressin analogue used in patients with decompensated cirrhosis, gastrointestinal haemorrhage or hepatorenal syndrome. It directly binds to V1 receptors improving circulatory volume by causing splanchnic vasoconstriction and portal hypertension inhibition, and has a full V2 receptor agonism in the collecting duct. In consequence, it increases reabsorption of water and can lead to a decrease in plasma osmolality and hyponatremia....

ea0090rc6.3 | Rapid Communications 6: Endocrine-related Cancer | ECE2023

Efficacy and safety of temozolomide in the treatment of aggressive pituitary neuroendocrine tumours in Spain

Lamas Cristina , Remon Pablo , Soto-Moreno Alfonso , Fajardo-Montanana Carmen , Biagetti Betina , Guerrero Fernando , Castro Marta Araujo , Mora Mireia , Hanzu Felicia Alexandra , Iglesias Pedro , Garcia Centeno Rogelio , Camara-Gomez Rosa

Introduction: Current guidelines propose temozolomide (TMZ) as the first-line chemotherapy for aggressive pituitary neuroendocrine tumors (PitNETs), but no clinical trials have been conducted and clinical experience in this context is limited.Patients and methods: A retrospective study of patients with aggressive pitNETs treated with TMZ was conducted by the members of the Neuroendocrinology Working Area of the Spanish Society of Endocrinology and Nutrit...

ea0090ep683 | Pituitary and Neuroendocrinology | ECE2023

Evaluation of the ACTH-CLU index for the differential diagnosis of ACTH-dependent Cushing’s syndrome

Izquierdo Belen Garcia , Rodriguez Delgado Laura , Araujo Castro Marta , Abad Lopez Ainhoa , Garcia Gomez Carlos , Rubio Ramos Miguel , Guzman Sanz Jorge , Diez Fernandez Natalia , Capristan Diaz Vanessa , Palacios Nuria

Introduction: Differentiation between Cushing’s disease (CD) and ectopic Cushing’s syndrome (ECS) remains a diagnostic challenge. Currently available tests lack sufficient sensitivity and specificity or are invasive and technically difficult. Recently, an ACTH-UFC index has been proposed to differentiate the two forms of ACTH dependent Cushing’s syndrome (CS) (Ding, 2021). This work aimed to confirm the diagnostic utility of the ACTH-UFC index to differentiate C...

ea0049ep719 | Obesity | ECE2017

Testosterone deficiency in obese males: is insulin resistance the one to blame?

Souteiro Pedro , Magalhaes Daniela , Pedro Jorge , Oliveira Sofia Castro , Neves Joao Sergio , Belo Sandra , Costa Maria Manuel , Bettencourt-Silva Rita , Varela Ana , Queiros Joana , Freitas Paula , Carvalho Davide , Group AMTCO

Introduction: Obesity is a growing worldwide public health issue and it is associated with multiple comorbidities, namely the so called Male Obesity-associated Secondary Hypogonadism (MOSH). However, the mechanisms that explain this association are not fully understood.Methods: Cross-sectional study of 163 obese men that were evaluated for several clinical and analytic parameters. Testosterone deficiency was defined as: total testosterone <2.8 ng/ml ...

ea0041ep793 | Obesity | ECE2016

Obstructive sleep apnoea syndrome – longitudinal outcomes and improvement predictors after bariatric surgery

Bettencourt-Silva Rita , Magalhaes Daniela , Souteiro Pedro , Sergio Neves Joao , Castro Oliveira Sofia , Manuel Costa Maria , Saavedra Ana , Bettencourt-Silva Marilia , Almeida Leonor , Drummond Marta , Queiros Joana , Varela Ana , Freitas Paula , Correia Flora , Carvalho Davide , AMTCO group Davide

Background: Bariatric surgery has been associated with a decrease in multiple obesity-related comorbidities including obstructive sleep apnoea syndrome (OSA). This study aims to access the OSA evolution in obese patients who underwent bariatric surgery.Methods: Retrospective longitudinal study of a population of obese patients who underwent bariatric surgery between January/2010 and July/2014 in our centre. Only patients who have undergone polysomnograph...

ea0035p460 | Diabetes complications | ECE2014

The influence of type 2 diabetes mellitus on periodontal disease

Silva Joao , Correia Diana , Marcelino Mafalda , Lopes Ana , Fernandes Nicholas , Ferreira Ana Lucia , Troles Tiago , Domingues Andreia , Passos Dolores , Lopes Luis , Figueiredo Joana , Luis Henrique , Silva Nuno , Mendes Jose Joao , Castro Joao Jacome de

The relationship between periodontitis and diabetes mellitus (DM) is widely accepted. Several studies identified a greater incidence of periodontitis and an increase of its severity in diabetic patients, approximately threefold.In this study, we want to investigate the influence of type 2 DM (T2DM) in the development of periodontitis.Single center, randomized trial with 90 patients T2DM. Exclusion criteria: chronic renal disease (G...